Skip to main content

Table 5 Objective adherence represented as MPR

From: Impact of a community pharmacist-led medication review on medicines use in patients on polypharmacy - a prospective randomised controlled trial

 

Intervention

Control

 

Mean %

SD

N

Mean %

SD

N

pValue

All therapies

88.3

19.03

493

87.5

20.75

527

0.811

Antiplatelets (B01AC)

91.3

16.24

61

85.4

23.75

64

0.119

Proton pump inhibitors (A02BC)

91.8

13.36

43

87.7

18.27

33

0.493

Back to article page

BMC Health Services Research

ISSN: 1472-6963

Contact us